Oric Pharmaceuticals
Price & Volume
Stats
See more52W Range | $6.33-$16.65 |
Market Cap | $676.7M |
Shares Short | 11M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.82 |
News
See moreYahoo Finance • last year
ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
Yahoo Finance • last year
ORIC Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operational Updates
Yahoo Finance • last year
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
About
CEO | Dr. Jacob M. Chacko M.B.A., M.D. |
Address | 240 East Grand Avenue, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 112 |
